Work

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Year: 2015

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv310

Authors: Y. Nieto, S.-M. Tu, R. Bassett, R.B. Jones, A.M. Gulbis, N. Tannir, A. Kingham, C. Ledesma, K. Margolin, L. Holmberg, R. Champlin, L. Pagliaro

Institutions: The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2149678989

FWCI: 4.691

Cites: 43

Cited by: 32

Related to: 10